Skip to search formSkip to main contentSkip to account menu

MDL 62,476

Known as: MDL 62476, MDL-62,476, MDL-62476 
National Institutes of Health

Related topics

Related topics

1 relation
A 40926

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Initial Quality Control Evaluations for Susceptibility Testing of Dalbavancin (BI397), an Investigational Glycopeptide with Potent Gram-Positive Activity
As gram-positive pathogens have acquired resistances to traditional therapeutic agents and multidrug-resistant clones have spread… 
Highly Cited
2001
Highly Cited
2001
In Vitro Evaluation of BI 397, a Novel Glycopeptide Antimicrobial Agent
Abstract BI 397, a semi-synthetic amide derivative of the experimental glycopeptide, MDL 62,476 (A40926), has excellent In Vitro… 
1995
1995
Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic
MDL 63,246 is a semisynthetic derivative of the naturally occurring glycopeptide antibiotic MDL 62,476 (A40926). It was more… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)